References
- Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311: 17–58
- Schuler G, Schuler-Thurner B, Steinman RM. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003; 15: 138–47
- Dhodapkar MV, Steinman RM, Sapp M, et al. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest 1999; 104: 173–80
- Gilboa E, Nair SK, Lyerly HK. Immunotherapy of cancer with dendritic cell-based vaccines. Cancer Immunol Immunother 1998; 46: 82–7
- Schadendorf D, Nestle FO. Autologous dendritic cells for treatment of advanced cancer: an update. Recent Results Cancer Res 2001; 158: 236–48
- Schuler G, Schuler-Thurner B, Steinman RM. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003; 15: 138–47
- Ardavin C, Amigorena S, Reis e Sousa C. Dendritic cells: immunobiology and cancer immunotherapy. Immunity 2004; 20: 17–23
- Schadendorf D, Ugurel S, Schuler-Thurner B, et al. Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol 2006; 17: 563–70
- Schendel DJ. Dendritic cell vaccine strategies for renal cell carcinoma. Expert Opin Biol Ther 2007; 7: 221–32
- Kyte JA, Gaudernack G. Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells. Cancer Immunol Immunother 2006; 55: 1432–42
- Li L, Giannopoulos K, Reinhardt P, et al. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts. Int J Oncol 2006; 28: 855–61
- Garderet L, Cao H, Salamero J, et al. In vitro production of dendritic cells from human blood monocytes for therapeutic use. J Hematother Stem Cell Res 2001; 4: 553–67
- Babatz J, Rollig C, Oelschlagel U, et al. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study. J Hematother Stem Cell Res 2003; 12: 515–23
- Curti A, Isidori A, Ferri E, et al. Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy. Leuk Lymphoma 2004; 45: 1419–28
- Nguyen XD, Eichler H, Sucker A, et al. Collection of autologous monocytes for dendritic cell vaccination therapy in metastatic melanoma patients. Transfusion 2002; 42: 428–32
- Figdor CG, de Vries IJ, Lesterhuis WJ, et al. Dendritic cell immunotherapy: mapping the way. Nature Med 2004; 10: 475–80
- de Vries IJ, Eggert AA, Scharenborg NM, et al. Phenotypical and functional characterization of clinical grade dendritic cells. J Immunother 2002; 25: 429–38
- Moroff G, Eichler H, Brand A, et al. Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood. Transfusion 2006; 46: 507–15
- Westermann J, Korner IJ, Kopp J, et al. Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties. Cancer Immunol Immunother 2003; 52: 194–8